Studies have found that individuals with initial colon cancer have a significantly increased risk, approximately 7–8 times higher CD133+ cells than normal cells, and CD133+ cells derived from metastatic cells had higher Hedgehog pathway activation than non-metastatic cells [88]. This evidence concerns the gene PROM1 and malignant colon neoplasm.